Delivery Order SPE2DB22D9353-SPE2DB24FX1WV
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,217.60, is for the delivery of Stelara 130 mg/26 ml vials to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Stelara 130 mg/26 ml vials, with a ceiling value of $10,099.68 and an ultimate completion date of July 1, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of STELARA 130 MG/26 ML VIAL 26ML, a specialized pharmaceutical product, with a total ceiling value of $7,574.76 and a performance period through January 27, 2025. The contract is a firm fixed-price delivery order and is not associated with any set-aside...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,312.30, is for the delivery of 130 mg/26 mL vials of the medication Stelara. The contract has an ultimate completion date of April 8, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,461.12, is for the supply of Stelara 130 mg/26 ml vials. The order falls under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to issue delivery orders for a comprehensive range of branded and generic...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of a specialized pharmaceutical product, Stelara (130 mg/26 ml vial), with a ceiling value of $12,435.20 and an ultimate completion date of January 10, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $7,461.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4564977234 - STELARA 130 MG/26 ML VIAL 26ML, and has a completion date of July 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
- This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,574.76, is a firm fixed-price delivery order for the supply of STELARA 130 MG/26 ML VIAL 26ML to the Defense Logistics Agency (DLA), the alternate name for which is the Medical Supply Chain. The contract has an ultimate completion date of July 9, 2025. DMS Pharmaceutical Group Inc. holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 130 mg/26 mL vials of the biologic drug Stelara, with a ceiling value of $5,049.84 and a period of performance through July 17, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. DMS Pharmaceutical...
- This is a $25,249.20 firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA) and will deliver Stelara 130 mg/26 ml vials to fulfill medical supply needs for the Department of Defense healthcare system. The contract has an ultimate completion date of August 1, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB24FX1WVDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Stelara 130 mg/26 ml vials and has a ceiling value of $3,730.56. The contract is a firm fixed-price delivery order, with a period of performance through May 10, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The company has provided a wide array of pharmaceutical products, including both common and specialized medications, to support the diverse medical requirements of the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 4/19/24 |